Kurzporträt
Mitarbeiterzahl: 46
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Markus Renschler
CEO | Chief Executive Officer | 63 | 01.05.16 |
David Gaiero
DFI | Director of Finance/CFO | 45 | 01.12.20 |
Susan Doleman
CTO | Chief Tech/Sci/R&D Officer | - | 01.08.19 |
Judson Englert
CTO | Chief Tech/Sci/R&D Officer | - | 01.06.20 |
General Counsel | - | 03.05.22 | |
Gale Cohen
HRO | Human Resources Officer | - | 01.05.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
John Thero
BRD | Director/Board Member | 63 | 04.02.22 |
Markus Renschler
CEO | Chief Executive Officer | 63 | 01.05.16 |
Jean George
BRD | Director/Board Member | 66 | 01.04.13 |
Chairman | 60 | 01.01.18 | |
Stephen Sands
BRD | Director/Board Member | 67 | 22.02.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 36 005 401 | 33 493 836 ( 93,02 %) | 7 333 ( 0,0204 %) | 93,02 % |
Unternehmenskontakt
![Straße Cyteir Therapeutics, Inc.(CYTT)](https://cdn.zonebourse.com/static/address/123863828.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+19.41% | 45.51 Mrd. | |
-8.62% | 38.52 Mrd. | |
+38.65% | 38.13 Mrd. | |
+26.95% | 30.74 Mrd. | |
-13.50% | 26.03 Mrd. | |
+10.74% | 25.92 Mrd. | |
+44.87% | 14.13 Mrd. | |
+34.36% | 12.73 Mrd. | |
-7.14% | 11.29 Mrd. |